PROGRAMME
Patients
Quality
Value
Sustainability
Partnership
increasing patient
quality, safety and
investors in
160.000 jobs across
key partners for
access
efficacy
innovation
Europe
public health
Wednesday 14 June
16:30
18:30
--PRICING & REIMBURSEMENT-Pre-Conference Workshop 1: Pricing and Reimbursement Policies around Generic Medicines
Chair | Michele Uda, Director General – Assogenerici and Chair EMAC – Medicines for Europe
Panel





16:30
18:30
Helder Mota-Filipe, Associate Professor of Faculty of Pharmacy, University of Lisbon and former
Member of the Executive Board – National Authority of Medicines and Health Products (Infarmed
I.P.)
Jaime Espin, Professor – Andalusian School of Public Health
Giovanni Tafuri, Senior HTA Officer – Italian Medicines Agency (AIFA)
Németh Gergely, Project Manager – National Health Insurance Fund of Hungary (OEP)
Victor Lino Mendonça, Head of Policy and Market Access Europe – Mylan
--ETHICS-Pre-Conference Workshop 2: International Consensus Framework on Ethics in the Healthcare Sector
Chair | Michael Fadus, Vice President of Compliance – Teva
Panel
 Ema Paulino, Professional Secretary FIP Executive Committee and President Lisbon and South
Branch of the Portuguese Pharmaceutical Society
 Robert Andrew Johnstone, Patient Advocate
 Christophe Lesguer, CCO, Chief Compliance Officer Europe – Mylan GmbH
 Heikki Pälve, CEO – Finnish Medical Association
Follow the event on twitter #IGBAMedicinesforEU
Lucia Romagnoli - T: +44-7562-876873 - E: [email protected]
www.medicinesforeurope.com/events
16:30
18:30
--COMMUNICATIONS-Pre-Conference Workshop 3: #AccessHealth, what’s behind a hashtag?
Chair | John Gisborne, Managing Director and Senior Partner – FleishmanHillard Fishburn
Panel
 Aidan Fry, Editor – Generics Bulletin
 Paul Tunnah, CEO and Founder – Pharmaphorum
 Laetitia Tonel, Head of Communications – Mylan Europe
 Chris Lewis, Senior Manager External Communications – Sandoz Global Communications
 James Duggan, Principal Medical Writer – 90TEN/IGBA Biosimilar Medicines Communication Project
 Evan O’Connell, Communications and Public Affairs Specialist – Aspect Consulting
16:30
18:30
--TRADE-Pre-Conference Workshop 4: Business Opportunities in External Markets and Access to Medicines –
An Assessment of the International Affairs Committee
Chair | Sergio Napolitano, Legal and External Relations Director – Medicines for Europe
Panel
 Alan Sheppard, Principal, Global Generics and Biosimilars, Thought Leadership – QuintilesIMS
 Alejandro Ollé, Partner and Co-founder – Galenicum
 David Jauch, Senior Manager Global Regulatory Affairs, Government Relations – Fresenius Kabi
 Oleh Syarkevych, Business Development Director – Farmak JSC
 Natalia Matting, Lawyer – DG Trade, European Commission
 Koen Nauwelaerts, Quality and Regulatory Manager – Medicines for Europe
20:00
Follow us on
Welcome Cocktail sponsored by
and Conference Registrations
Medicines for Europe AISBL
Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38
www.medicinesforeurope.com
Thursday 15 June
08:00
Welcome Coffee and Registration
09:00
--OPENING ADDRESS-Jacek Glinka, President – Medicines for Europe
--OPENING KEYNOTE SPEECH-Maria do Céu Machado, President – INFARMED
09:30
--SUSTAINABILITY-Better Access, Better Health: our Industry’s Vision on Sustainability of Healthcare
Chair | Adrian van den Hoven, Director General – Medicines for Europe
Panel






Rabia Khan, Health Policy Analyst – OECD
Christa Cepuch, Pharmacist Coordinator – MSF Access Campaign
Alex Harris, CEO – International Health Partners
Robert Andrew Johnstone, Patient Advocate
Pierluigi Antonelli, Head Western Europe – Sandoz International
Jacek Glinka, President Europe – Mylan
11:00
Networking Coffee break
11:40
--DEVELOPED MARKETS-Global Update of Generic Medicines in Developed Markets
Chair | Jim Keon, President – Canadian Generic Pharmaceutical Association and President, Biosimilars
Canada
Panel
 Alan Sheppard, Principal Thought Leadership Global Generics and Biosimilars – QuintilesIMS
 Kyozo Inari, Executive Corporate Officer – Sawai Pharmaceutical Co., Ltd. and Chair of International
Affairs Committee – JGA
 John McCullough, VP Commercial Generics Europe and Global In Line Portfolio Management – Teva
 Tony Mauro, Chief Commercial Officer – Mylan
13:00
Follow us on
Networking Buffet Lunch sponsored by
Medicines for Europe AISBL
Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38
www.medicinesforeurope.com
14:00
--GLOBAL MANUFACTURING--
--PROCUREMENT--
Making Generic and Biosimilar Manufacturing
Thrive: A Global Policy
Chair | Michele Uda, Director General –
Assogenerici and Chair EMAC – Medicines for
Europe
A Concerted Approach to Tackle Economic and
Regulatory Aspects of Shortages
Chair | Marc-Alexander Mahl, Executive Vice President,
Business Unit Generic Drugs – Fresenius Kabi and Chair
of the Hospital Working Group – Medicines for Europe
Panel
 Gian Mario Baccalini, President –
Aschimfarma and Chair – European Fine
Chemicals Group
 Dinesh Dua, Vice Chairman –
Pharmaceuticals Export Promotion
Council of India
 Satoshi Kawamura, Senior Vice
President – Nipro Pharma Corporation
 Jody Cox, Vice President Federal and
International Affairs, Canadian Generic
Pharmaceutical Association and Vice
President, Biosimilars Canada
Panel
 Annie Pannelay, Principal – The Economist
Intelligence Unit
 Maggie Dolan, Regional Pharmacy Procurement
Specialist – NHS Commercial Solutions Surrey
 Aida Batista, Board Member, Director of
Professional Development – European Association
of Hospital Pharmacists
 Marcel T. M. van Raaij, Director Ministry of
Health – The Netherlands
 Dominik Tomek, Board Member – European
Patients Forum
 Yi-Yun (April) Wang, Legal Manager - Yung Shin
Pharm. Ind. Co., Ltd. and Chair, International
Affairs Committee – Taiwan Generic
Pharmaceutical Association
15:20
Networking Coffee Break
16:00
--INTERNATIONAL CONVERGENCE--
--VALUE ADDED MEDICINES--
International Regulatory and Supply Chain
Cooperation
Chair | David Gaugh, Senior Vice President,
Sciences and Regulatory Affairs – AAM
A New Value Proposition for Patients, Healthcare
Practitioners and Systems
Chair | Christoph Stoller, SVP, Chief Operating Officer
GGM Europe – Teva Pharmaceuticals Europe B.V. and
Vice-President – Medicines for Europe
Panel
 Sabine Kopp, Group Lead, Medicines
Quality Assurance – WHO
 Brendan Cuddy, Head of Manufacturing
and Quality Compliance – EMA
 Nuala Calnan, Senior Associate –
Lachman Consultant Services, Inc.
 Mechthild Sander, Qualified Person –
Alfred E. Tiefenbacher
Follow us on
Panel

Mondher Toumi, Professor – University of AixMarseille
 Robert Andrew Johnstone, Patient Advocate
 Sampreet Ramachandra, Director of Strategy –
Fresenius Kabi
 Antonio Vaz Carneiro, Head – Centre for
Evidence-Based Medicine (CEMBE) - Faculty of
Medicine of the University of Lisbon
Medicines for Europe AISBL
Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38
www.medicinesforeurope.com
17:20
18:30
--WOMEN’S LEADERSHIP & PHARMA
Interactive session: Q&A with influential women in healthcare
Chair | Hanan J. Sboul, Secretary General – Jordanian Association of Pharmaceutical Manufacturers
Panel
 Carol Lynch, Global Head of Biopharmaceuticals – Sandoz / Chair of the Biosimilar Medicines Group
 Catarina Nobre, President – EPSA
 Elisabeth Stampa, CEO – Medichem SA
 Suzette Kox, Senior Director International – Biosimilar Medicines Group
 Belinda Wood, CEO – Generic and Biosimilar Medicines Association (GBMA), Australia and Vice-Chair
of the IGBA Biosimilars Committee
19:30
Conference Dinner sponsored by
Friday 16 June
08:00
Networking Coffee
09:00
--OPENING ADDRESS—
Paulo Lilaia, President – Apogen (Portuguese Association for Generic and Biosimilar Medicines)
--OPENING SPEECH—
José Inácio Faria, MEP – EPP Portugal
09:20
--BUSINESS-A Discussion with the Global Leaders and Analysts
Chair | John Hodgson, Executive Editor – In Vivo, Informa Pharma Intelligence Group
Panel






10:40
Follow us on
Elisabeth Stampa, CEO – Medichem
Enrique Ordieres, President – Cinfa
Jeremy B. Desai, CEO – Apotex Inc.
Frances Cloud, Founder – Pharmacloud
Randall Stanicky, Managing Director – RBC Capital Markets
Simon Goeller, Partner – McKinsey & Company
Networking Coffee Break
Medicines for Europe AISBL
Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38
www.medicinesforeurope.com
11:30 --EMERGING MARKETS—
Unlocking Pharma Growth – Emerging Markets
Chair | Rafael Enrique Maciel Martínez, President – AMEGI
Panel
 Jean Mina, Associate Partner – McKinsey & Company
 Abdallah Mazahreh, Marketing Director / MENA & Emerging Markets – Pharma International
Company
 Vivian Frittelli, CEO – NAPM (South Africa)
 Dilip G Shah, Secretary General – IPA (South Asia and India)
 Keh Song Hock, Executive Director – Malaysian Organisation of Pharmaceutical Industries (Southeast
Asia)
 Talgat Nurgozhin, Director – Center for Life Sciences, “National Laboratory “Astana”, Nazarbayev
University (Central Asia and Eastern Europe)
12:45
Networking Buffet Lunch sponsored by
14:00
--BIOSIMILAR MEDICINES-Global Market Policies for Biosimilar Medicines
Chair | Belinda Wood, CEO – Generic and Biosimilar Medicines Association (GBMA), Australia
and Vice-Chair of the IGBA Biosimilars Committee
Panel
 Maggie Dolan, Regional Pharmacy Procurement Specialist – NHS Commercial Solutions Surrey
 Gillian Woollett, Senior Vice President – Avalere Health
 Suzanne McGurn, Assistant Deputy Minister (ADM) and Executive Officer (EO) – Ontario Public Drug
Programs
 Hiroyuki Sakamaki, Professor – Tokyo University of Science
 Florian Turk, Global Head Payor Marketing, Sales and Engagement – Sandoz and Vice-Chair of the
Market Access Committee of the Biosimilar Medicines Group, a Medicines for Europe Sector Group
15:20 --CLOSING REMARKS-Adrian van den Hoven, Chairman – IGBA
Please note that there will be simultaneous translation
English-Portuguese available.
Follow us on
Medicines for Europe AISBL
Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38
www.medicinesforeurope.com
SPONSORS
MEDIA PARTNERS
Follow us on
Medicines for Europe AISBL
Rue d’Arlon 50 - 1000 Brussels – Belgium
T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38
www.medicinesforeurope.com